DIRECT™: Display Integrated
Rational Engineering for the
Creation of Therapeutics
MLAB Biosciences is a biotechnology company that leverages its proprietary DIRECT™ platform to discover and develop novel antibody-based therapies for muscular dystrophies and other unmet medical needs.
MLAB Biosciences is incubated by ABio-X Holdings, Inc., backed by CBC Group.